[Ad hoc announcement pursuant to Art. 53 LR] Roche announces the repurchase of the equity stake held by Novartis in RocheGlobeNewsWire • 11/04/21
Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer SettingBenzinga • 11/02/21
IMPACT trial data shows clear benefit in using Roche's CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancerGlobeNewsWire • 10/29/21
The Hanover Insurance Group, Inc. (THG) CEO Jack Roche on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/28/21
Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetesPRNewsWire • 10/28/21
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer researchGlobeNewsWire • 10/25/21
FDA Approves Genentech's Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)Business Wire • 10/22/21
FDA approves Roche's Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD)GlobeNewsWire • 10/22/21
Roche's VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab)GlobeNewsWire • 10/22/21
Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised)Zacks Investment Research • 10/21/21
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months – outlook for 2021 raisedGlobeNewsWire • 10/20/21
Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient carePRNewsWire • 10/18/21